Write in a clean editor, then format for Journal of the Canadian Association of Gastroenterology in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of the Canadian Association of Gastroenterology is a peer-reviewed journal published by Oxford University Press, covering Inflammatory Bowel Disease, Microscopic Colitis, Colorectal Cancer Screening and Detection.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Journal of the Canadian Association of Gastroenterology, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — Journal of the Canadian Association of Gastroenterology has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Inflammatory Bowel Disease Microscopic Colitis Colorectal Cancer Screening and Detection Gut microbiota and health Gastric Cancer Management and Outcomes |
| ISSN | 2515-2084 |
| Citation impact (2-yr) | 0.26 |
| h-index | 30 |
| i10-index | 145 |
| Total citations | 5,272 |
| Article processing charge | $1,993 |
| Open access | Yes |
| Top institutions publishing here | University of Calgary |
| Journal website | academic.oup.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal (GI) disorders, affecting about 10% of the general population globally. The aim of this consensus was to develop guidelines for the management of IBS. METHODS: A systematic literature search identified studies on the management of IBS. The quality of evidence and…
Canada has among the highest incidence and prevalence of inflammatory bowel disease (IBD) in the world. After decades of rising incidence of IBD in Canada during the 20th Century, the prevalence of IBD in 2018 is 0.7% of the Canadian population. Forecasting models predict that prevalence of IBD will continue to rise to 1.0% of…
Canada has among the highest rates of childhood-onset IBD in the world. Over 7000 children and youth under 18 years old are living with IBD in Canada, and 600 to 650 children under 16 years old are diagnosed annually. While the peak age of onset of IBD is highest in the second and third decades…
Inflammatory bowel disease (IBD) has a substantial impact on quality of life. It causes considerable personal, emotional and social burdens. The impact of IBD on quality of life cannot readily be quantified as a cost; however, the impact places a significant burden on the patient and caregivers. Numerous studies have shown that health-related quality of…
Direct health care costs of illness reflect the costs of medically necessary services and treatments paid for by public and private payers, including hospital-based care, outpatient physician consultations, prescription medications, diagnostic testing, complex continuing care, and home care. The costs of caring for persons with inflammatory bowel disease (IBD) have been rising well above inflation…
